Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 978032Generated: October 26, 2026

Triethylamine → N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramide

https://huagongshe.com/reaction/978032

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantN-Ethyl cyclohexylamineHCID 21609—
ReactantIsobutyl chloroformateHCID 62365—
Reactant5-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)valeric acidHCID 13203402—
SolventTetrahydrofuranHCID 8028—
ProductN-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramideHCID 1320339775.6%

Reaction Steps

5-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)valeric acid (2.4 g) is dissolved in tetrahydrofuran (50 ml), and thereto is added triethylamine (1.1 g). To the mixture is added dropwise with stirring isobutyl chloroformate (1.5 g) under ice-cooling, and the mixture is stirred at room temperature for 30 minutes. To the mixture is added dropwise with stirring N-ethyl-cyclohexylamine (1.5 g) at room temperature, and the mixture is further stirred for 2 hours. After distilling off tetrahydrofuran, water is added to the residue, and the mixture is extracted with chloroform. The chloroform layer is washed with an aqueous saturated sodium chloride solution and dried over magnesium sulfate. Chloroform is distilled off, and the resulting residue is subjected to column chromatography (Kieselgel 60, made by Merck & Co., eluting solvent, chloroform) to isolate N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramide (2.6 g), white crystalline powder (ether), m.p. 92°-95° C.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04663323
Source datasetuspto-grants-1987_05
ORD IDord-31c072aa22fb4fdd875781c1ba6b6dec
Source noteuspto-grants-1987_05